Detalles de la búsqueda
1.
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99.
BMC Cancer
; 20(1): 114, 2020 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32046665
2.
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
BMC Cancer
; 19(1): 902, 2019 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500588
3.
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC).
Cancer Immunol Immunother
; 67(12): 1825-1832, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171269
4.
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling.
J Transl Med
; 15(1): 66, 2017 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28359318
5.
Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
Gynecol Oncol
; 145(2): 374-385, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28188016
6.
Improved survival of older patients with multiple myeloma in the era of novel agents.
Hematol Oncol
; 34(4): 217-223, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25898820
7.
Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience.
Support Care Cancer
; 24(5): 2119-2128, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553033
8.
Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses.
Int J Hyperthermia
; 32(7): 809-21, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27411568
9.
Cancer-related therapies at the end of life in hospitalized cancer patients from four Swiss cantons: SAKK 89/09.
Oncology
; 88(1): 18-27, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25277324
10.
High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA).
J Biomed Inform
; 58: 175-185, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26483173
11.
Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09).
BMC Cancer
; 14: 306, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24885104
12.
Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer.
Support Care Cancer
; 21(11): 3085-93, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23828394
13.
Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis.
Clin Cancer Res
; 29(8): 1468-1476, 2023 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716289
14.
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
Haematologica
; 97(7): 1085-91, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22315486
15.
Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trial.
Ann Hematol
; 91(4): 613-20, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21956636
16.
Electronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC.
BMC Palliat Care
; 11: 19, 2012 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-23006802
17.
Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA.
Clin Lymphoma Myeloma Leuk
; 22(8): e804-e814, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35595618
18.
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.
Eur J Cancer
; 152: 223-232, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34147014
19.
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol
; 38(12): 1322-1331, 2020 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31877087
20.
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
JAMA Netw Open
; 3(10): e2021692, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33112397